Massachusetts Institute of Technology, in collaboration with University College London, is announcing its 2021 Vaccines BioProcess Development & Commercialization Workshop.
This three-day workshop will explore the critical issues at the various stages of vaccine development. International experts with over 10 years’ experience in their field will lead delegates in developing their understanding in the research, development, operational and regulatory challenges of the vaccine market. In addition to expert lectures and excellent networking opportunities with your peers, one case study will be conducted during the workshop about manufacturing at-risk with real examples from the influenza manufacturing process.
This workshop is suitable for:
• Scientists and engineers new to the vaccines sector (recent graduates/ research scientists).
• Scientists and technical managers who wish to broaden their knowledge in various vaccine technologies and platforms, exploring the interplay between process choices and regulation.
• Project Managers, funders and policy-makers wanting to gain an understanding of vaccines.
Confirmed Speakers Include:
Alison Armstrong, Merck Group
Dan Barouch, Harvard
Barry Buckland, UCL
Tania Pereira Chilima, Univercells
Kimberly Duffy, Merck
Mark Feinberg, IAVI
Stefanie Frank, UCL
Adrian Hill, Oxford
Steve Kolodziej, Pfizer
J. Christopher Love, MIT
Peter Marks, FDA
Martina Micheletti, UCL
Derek O’Hagan, GSK
Julia O’Neill, Moderna
Don Parsons, Moderna
David Robinson, B&MGF
Stacy Springs, MIT
Dave Sullivan, Pfizer
Unless otherwise specifically stated in relation to each and any of the events listed on this page, the MLSC does not host or sponsor these events. The MLSC has no oversight or responsibility for the venue, content or host-organization related to these events. The MLSC has no affiliation with the organizations listing events or with the events, and provides this content and information as a convenience to visitors to the MLSC website.
